Moderna finalizes strategic partnership with australian government

On-shore manufacturing facility based in melbourne, australia, expected to produce up to 100 million mrna respiratory vaccine doses annually cambridge, ma / accesswire / march 23, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced the finalization of a strategic partnership with the australian federal government to establish a state-of-the-art, domestic mrna vaccine manufacturing facility in australia. this finalizes the agreement in principle with the australian federal government announced in december 2021.
MRNA Ratings Summary
MRNA Quant Ranking